Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee.
about
Coronary artery flow reserve in diabetics with erectile dysfunction using sildenafilAnti-platelet therapy: phosphodiesterase inhibitors.Role of phosphodiesterase-5 inhibitors in heart failure: emerging data and concepts.Future prospects in the treatment of erectile dysfunction: focus on avanafil.New treatment for erectile dysfunction.Pulse wave analysis.Sublingual sildenafil in the treatment of erectile dysfunction: faster onset of action with less dose.The role of nitric oxide in erectile dysfunction: implications for medical therapy.New treatments for pulmonary arterial hypertension.Combination of sildenafil and simvastatin ameliorates monocrotaline-induced pulmonary hypertension in rats.Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator.Treatments for diabetic neuropathy.Erectile dysfunction and diabetes.Safety of sildenafil in infants*.Sometimes Poppers Are Not Poppers: Huffing as an Emergent Health Concern among MSM Substance Users.Quantification of glyceryl trinitrate effect through analysis of the synthesised ascending aortic pressure waveform.Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn: a review.Role of the cardiologist: clinical aspects of managing erectile dysfunction.Phosphodiesterase inhibitors in the management of primary pulmonary hypertension.The effect of tadalafil on the time to exercise-induced myocardial ischaemia in subjects with coronary artery disease.Erectile dysfunction: interrelationship with the metabolic syndrome.From aspiration to achievement: assessment and noninvasive treatment of erectile dysfunction in aging men.Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension.Effect of sildenafil citrate on the cardiovascular system.Erectile dysfunction and coronary atherothrombosis in diabetic patients: pathophysiology, clinical features and treatment.Advances in the medical treatment of pulmonary hypertension.The emerging role for type 5 phosphodiesterase inhibition in heart failure.Sildenafil for pulmonary arterial hypertension: when blue turns into white.A literature review: the effects of magnetic field exposure on blood flow and blood vessels in the microvasculature.A multicenter, randomized, open-labeled, parallel group trial of sildenafil in alcohol-associated erectile dysfunction: the impact on psychosocial outcomes.PDE5 inhibitors: considerations for preference and long-term adherence.Sexual activity and ischemic heart disease.Comparison of preventive effect of sildenafil and therapeutic effect of sildenafil treatment in rats with monocrotaline-induced pulmonary arterial hypertension.Sildenafil enhances locomotor activity in young mice and exerts anxiogenic effects in both young and aged mice.Phosphodiesterase 5 inhibition attenuates cerebral vasospasm and improves functional recovery after experimental subarachnoid hemorrhage.A review of pulmonary arterial hypertension: Part 2: Current and expected treatments.Angiogenesis and improved cerebral blood flow in the ischemic boundary area detected by MRI after administration of sildenafil to rats with embolic stroke.Noninvasive assessment of acute cardiopulmonary effects of an oral single dose of sildenafil in patients with idiopathic pulmonary hypertension.Effect of sildenafil-induced nitric oxide on the histomorphology of cardiomyocytes in male rats.Viagra for impotence of pulmonary vasodilator therapy?
P2860
Q24798647-044E485C-C8FE-49A7-9225-78BCD52800EEQ27687228-3BB4399D-45F5-4C5F-8050-25893C83B943Q30575578-C5235412-C680-44E6-98B8-6D479FCEAD25Q34029414-C06022FA-D4AC-4236-9032-6B298C73E883Q34108390-08C8DB37-4548-43B1-B114-C64F2CBE084CQ34291273-A48509EF-6E75-4E66-A2A4-6C314B7A4E3CQ34362478-8852E95A-2690-49D6-8D74-D31D42AEBA00Q34591304-2EB7A86A-96A7-4546-B6E1-32B66ED3F691Q34625826-AEC23442-9CB4-4FA4-8D5E-6F05E8AF6950Q35024562-B6A130A2-BB0F-47CD-B600-764FED2D39BBQ35068163-113E142E-766F-474C-965B-6684840041B7Q35087362-46F5451D-C650-492A-9940-2FFA2B6E38EEQ35087402-275B7DE4-665B-4315-9005-5B18E41BC3E6Q35105255-B781517C-756E-4393-ACE2-28362241B192Q35446749-88A43923-89DB-4F57-8866-E77BDB4BA5D2Q35580152-1508B274-579C-43C2-A557-944311BA5683Q35584277-2F5587FC-8A8F-4DDA-9B03-60A91FAEFD9AQ35759036-0332E4FA-2AFA-4D0F-A150-A4A4CCBF4FBBQ35767469-56E1A084-F65C-4616-B124-0101BCD6B2ACQ35827206-173CF529-1FDD-457D-9B16-FCAC4F1BA3FAQ36016959-2365A5BD-54D0-448B-B941-0048D4029D84Q36018485-CD32B87E-8DEB-496E-865E-7F0E7D7C1135Q36203104-782627CC-7875-4994-8489-A07933E0571EQ36247128-F9DDAD80-1637-4D09-98AF-56EDC2076CACQ36410421-18FB40A3-6CB7-4EB6-B90D-19819E1BEA94Q36420236-83C483A1-7909-4ECA-AE71-EE723B4AA449Q36567862-E74A53F1-A132-4386-AB5A-070B05FB693BQ36573907-572A5859-FDDE-4003-B53C-6FCD478AB4C2Q36605103-50BD00CD-4B6D-4FC7-88DD-B7D60BB23E7EQ37383825-DF096D41-D7F4-4094-8E71-83F6A1BE9F15Q38122721-33584AA6-EA23-4B34-B4A2-DA200328CE81Q38177225-C8485EA4-C374-4AC5-BCFD-AEE4C158FA98Q41671102-DF03792B-E38B-49A6-A354-C37D20798C4EQ41847930-3EB9A2F0-FD5F-45B8-AA93-25FBC2D32BE1Q42040524-F2CE5592-4836-447A-8603-DAE3C72B9905Q42340403-FA040EA5-46E0-4FAD-9B6F-30B3C8DF1629Q42757007-5894746F-CE1F-429D-81A0-673A46A17B34Q42949807-26B74093-28F5-4691-9886-21E3DE8ADAE1Q42967773-A3A71E26-513D-4B6F-AA21-6C02A143BB12Q43526116-32417E34-221C-4621-ABE7-BF4CB482EB5E
P2860
Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Use of sildenafil (Viagra) in ...... Practice Executive Committee.
@ast
Use of sildenafil (Viagra) in ...... Practice Executive Committee.
@en
Use of sildenafil
@nl
type
label
Use of sildenafil (Viagra) in ...... Practice Executive Committee.
@ast
Use of sildenafil (Viagra) in ...... Practice Executive Committee.
@en
Use of sildenafil
@nl
prefLabel
Use of sildenafil (Viagra) in ...... Practice Executive Committee.
@ast
Use of sildenafil (Viagra) in ...... Practice Executive Committee.
@en
Use of sildenafil
@nl
P2093
P356
P1433
P1476
Use of sildenafil (Viagra) in ...... Practice Executive Committee.
@en
P2093
Brindis RG
Cheitlin MD
Hutter AM Jr
Russell RO Jr
P304
P356
10.1161/01.CIR.99.1.168
P407
P577
1999-01-01T00:00:00Z